NEYROS CEO Discusses Joint Research with Cuba on New Parkinson’s Medication

T. K. Hernández ()

Chapter Chapter 33 in The Cuba Interviews, 2023, pp 331-334 from Springer

Abstract: Abstract Part VIII explores Cuba’s priority sectors: health, medical tourism, and biopharmaceuticals. It provides industry insights from doctors, executives, and an editor of a peer-reviewed medical journal. These interviews highlight the successes of the healthcare system, research and collaboration, investments, pharmaceuticals, vaccine development, joint ventures, and medical tourism. This chapter is an interview with the CEO of NEYROS, a start-up pharmaceutical research company in the Russian Federation. Dr. Dmitry Chelovskiy discusses collaboration with Cuba’s Center for Research and Development of Medicines (CIDEM). Supported by the Skolkovo Innovation Center in Moscow, the project studied neurological diseases focusing on a new Parkinson’s medication. At the time of this interview in April 2021, preclinical studies had been ongoing for three years.

Keywords: Cuba; Russia–Cuba; NEYROS; Center for Research and Development of Medicines; CIDEM; BioCubaFarma; Dmitry Chelovskiy; Skolkovo Innovation Center; Parkison’s disease (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-30203-9_33

Ordering information: This item can be ordered from
http://www.springer.com/9783031302039

DOI: 10.1007/978-3-031-30203-9_33

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().